Difference Between Medical and Nonmedical Students on Knowledge, Practice, and Attitude Towards the Human Papillomavirus Vaccine in China: a Cross-Sectional Study

Liu, Yingnan; Xue-xiang, Jiang; Xu, Lingyi; Di, Na; Jiang, Lu; Tao, Xin

doi:10.1007/s13187-019-01682-4

Cited by 6 publications

(6 citation statements)

References 18 publications

Supporting

Mentioning

Contrasting

Unclassified

Order By: Relevance

“…Similar to our study, in Spanish and Chinese studies medical students had a higher level of knowledge on HPV and its relationship with cancer and HPV vaccination than non‐medical students 11,15 . Spanish medical students also had a later age of sexual initiation, as in our study, but medical students from our study had the same HPV vaccination rates as their non‐medical counterparts.…”

Section: Discussionsupporting

confidence: 84%

“…11,14 Similar to our study, in Spanish and Chinese studies medical students had a higher level of knowledge on HPV and its relationship with cancer and HPV vaccination than non-medical students. 11,15 Spanish medical students also had a later age of sexual initiation, as in our study, but medical students from our study had the same HPV vaccination rates as their non-medical counterparts. In our study, students had poorer knowledge about HPV vaccination, lower HPV-related cancer awareness and lower vaccination rates than that reported in most of other European studies.…”

Section: Discussionmentioning

confidence: 49%

See 1 more Smart Citation

Differences in human papilloma virus vaccination prevalence, testing, knowledge on vaccination, cancer awareness and sexual activities between male and female medical and non‐medical students

Chernyshov

Semushyna²

2020

Acad Dermatol Venereol

View full text Add to dashboard Cite

Background Although most European countries experienced a decrease in cervical cancer mortality, Ukraine, Latvia and Belarus have experienced an increase in mortality. There is no national vaccination programme against human papilloma virus (HPV) in Ukraine, and vaccination rates are low. Objectives To study the knowledge of HPV-related cancers and vaccination amongst medical and non-medical students with a view to a better organization of educational interventions. Methods Male and female students of the Bogomolets National Medical University and non-medical students of other universities from Kiev were asked to fill in an anonymous survey of HPV vaccination prevalence, testing, knowledge on vaccination, HPV-related cancer awareness and sexual activities. Results Medical students showed better knowledge, higher prevalence of HPV testing and later sexual debut when compared to non-medical students. Female students showed higher awareness of HPV-related cancers except oral and rectal cancers and better knowledge of vaccination. The highest vaccination rate was in female medical students (6.56%) but the difference was not significant. First-to third-year students reported the lowest knowledge of all related aspects. Conclusions Despite the absence of a national HPV vaccination programme, all students should be informed that HPV vaccination is available and recommended for all young persons. They should also be informed that it is possible to buy the vaccine and that there is evidence of clear benefit of vaccination. Factors limiting vaccine uptake (other than high vaccine cost) should be addressed by educational interventions. Information campaigns for students in their 1st and 2nd years of studies are especially important.

show abstract

Section: Discussionsupporting

confidence: 84%

Section: Discussionmentioning

confidence: 49%

Differences in human papilloma virus vaccination prevalence, testing, knowledge on vaccination, cancer awareness and sexual activities between male and female medical and non‐medical students

Chernyshov

Semushyna²

2020

Acad Dermatol Venereol

View full text Add to dashboard Cite

show abstract

“…As the cost of vaccines is an important factor in government-funded immunization programs, the WHO endorsed the use of a two-dose HPV vaccination schedule to increase compliance and reduce costs [3,65]; the choice of vaccine should be based on locally relevant data such as the scale of prevailing HPV strains and the population for which it is approved [9]. Among the studies, only two from China reported the use of Gardasil-9 which is relatively costlier given its protection against nine types of HPV while the rest reported using the bivalent or quadrivalent vaccines [54,55]. Beginning in 2020, the fourth HPV vaccine product Cecolin was approved by the Chinese Food and Drug Administration and was found cost-effective in cervical cancer prevention in China [4] where the Cecolin is priced at US dollar 47.7 per dose while the imported Cervarix is priced at US dollar 262 for three doses, Gardasil at US dollar 360 for three doses and Gardasil-9 at US dollar 586 for three doses [4].…”

Section: Discussionmentioning

confidence: 99%

“…Five studies reported the use of Cervarix and Gardasil between 2009 and 2019 in Argentina, Brazil, China, Malaysia, and Nigeria [19,28,43,45,49,53]. Two studies reported the use of all three vaccines between 2018 and 2019 in China [54,55]. Sixteen studies reported the use of Gardasil alone in Bhutan, Bolivia, Brazil, Cambodia, Cameroon, Ghana, [17,53,57].…”

Section: Types Of Vaccines and Sponsorsmentioning

confidence: 99%

Human papillomavirus vaccination uptake in low-and middle-income countries: a meta-analysis

Dorji¹,

Nopsopon

Tamang³

et al. 2021

EClinicalMedicine

View full text Add to dashboard Cite

Background: The proportion of incident cases of HPV-attributable cancers is highest in the low-and middleincome countries (LMICs) but many are yet to initiate HPV vaccination programs. This meta-analysis was performed to assess the uptake of HPV vaccination in LMICs at the beginning of the global strategy to eliminate cervical cancer and describes the gaps and challenges. Methods: A systematic search was conducted in PubMed, EMBASE, Scopus, Web of Science, and CENTRAL databases for observational studies that reported the uptake of HPV vaccination until October 2020. The meta-analysis was done using a random-effects model to assess the pooled estimate of HPV uptake. CRD42021218429 Findings: During 2008À2020, an estimated 3.3 million females received at least one dose of HPV vaccine with 61.69% of the target population vaccinated. In countries with high uptake, the pooled estimate of uptake was higher in females than males (45.48% vs 8.45%) and showed significant decline in 2015À2020 compared to 2006À2014 (89.03% vs 41.48%). In countries with low uptake, the estimate of uptake was low in both males and females (5.31% vs 2.93%) and showed increase in uptake in 2015À2020 compared to 2006À2014 (0.76% vs 5.22%). In countries with high uptake, compared to routine programs, the estimate was higher when delivered through demonstration programs (89.94% vs 59.74%). Interpretation: The major concern was a significant drop in the uptake in countries that started with high uptake, challenges in the maintenance of vaccine uptake, sustainability of funding and the lack of standard monitoring and reporting.

show abstract

“…No entanto, foi superior a estimada entre estudantes da Itália (26,7%; IC 95%: 25,9-27,6) 8 , Letônia (3,3%; IC 95%: 1,0-7,8) 17 , China (8,8%; IC 95%: 5,9-12,5) 23 , Índia (6,8%; IC 95%: 5,3-8,5) 24 , Turquia (1,5%; IC 95%: 1,0-2,2) 25 e Hong Kong (23,3%; IC 95%: 19,5-27,6) 26 . A diferença entre as taxas de prevalência talvez possa ser explicada tendo em vista as características do país em estudo.…”

Section: Discussionunclassified

Fatores associados à não adesão à vacina contra HPV entre estudantes de ciências da saúde

et al. 2021

View full text Add to dashboard Cite

Introdução: Adolescentes e adultos jovens são considerados grupos vulneráveis a infecção pelo papilomavírus humano (HPV), devido a comportamentos sexuais de risco como maior número de parcerias e uso inconsistente do preservativo. No Brasil a vacina contra o HPV está disponível desde 2014, contudo a adesão ainda está abaixo do esperado. Objetivos: Identificar os fatores associados à não adesão à vacina, estado vacinal e conhecimento sobre o HPV entre estudantes de ciências da saúde em Goiânia. Materiais e Métodos: Estudo transversal, realizado com 131 participantes. Foi aplicado um questionário contendo questões sobre características sociodemográficas, conhecimento do HPV e estado vacinal. Regressão de Poisson foi realizada para identificar os preditores da não adesão a vacinação. Resultados: A maioria dos estudantes era do sexo feminino (81,7%), com média de idade de 17 anos. O escore de conhecimento sobre o HPV foi de 67,4%. Do total, 59 (45,0%) declararam-se vacinados. Os fatores associados à não adesão à vacina contra o HPV foram idade superior a 18 anos, sexo masculino e pais que tinham no máximo oito anos de estudo formal. Conclusão: Os achados deste estudo reforçam a necessidade de ações intersetoriais para promoção da vacinação, envolvendo as instituições de ensino e unidades de saúde, a fim de proporcionar um diálogo entre estudantes, pais, profissionais de saúde e docentes. Acredita-se que o acesso à informação qualificada possa contribuir para a mudança de comportamento e melhoria da tomada de decisão, levando os estudantes a refletirem sobre suas atitudes e riscos inerentes à infecção pelo HPV.

show abstract

Difference Between Medical and Nonmedical Students on Knowledge, Practice, and Attitude Towards the Human Papillomavirus Vaccine in China: a Cross-Sectional Study

Cited by 6 publications

References 18 publications

Differences in human papilloma virus vaccination prevalence, testing, knowledge on vaccination, cancer awareness and sexual activities between male and female medical and non‐medical students

Differences in human papilloma virus vaccination prevalence, testing, knowledge on vaccination, cancer awareness and sexual activities between male and female medical and non‐medical students

Human papillomavirus vaccination uptake in low-and middle-income countries: a meta-analysis

Fatores associados à não adesão à vacina contra HPV entre estudantes de ciências da saúde

Contact Info

Product

Resources

About